Continuously Deepening Expertise in Minimally Invasive Tumor Ablation and Promoting Academic Development: Professor Xiao Yueyong Conducts In-Depth Academic Exchange and Clinical Guidance at Uni-Asia
On July 18, Professor Xiao Yueyong, President of the World Association of Tumor Ablation (WATA) and a leading expert in the development of diagnostic and treatment standards for ablation techniques in China, visited our hospital to conduct a thematic academic exchange and clinical guidance. This in-depth academic exchange was not only an important step in promoting the hospital’s specialized development through the professional support of top experts, but also clearly demonstrated Chengdu Uni-Asia Cancer Hospital’s standardized capability and industry responsibility as WATA’s Clinical Model Hospital in the field of minimally invasive tumor ablation.
Professor Xiao Yueyong has more than 40 years of in-depth experience in minimally invasive interventional treatment of tumors. He pioneered the development of cryoablation treatment strategies for tumors, designed more than 20 innovative CT/MRI-guided interventional ablation techniques, led the formulation and publication of more than 10 expert consensus statements and guidelines on minimally invasive tumor ablation treatment, and has achieved numerous national-level scientific research accomplishments. As a key expert in establishing diagnostic and treatment standards for ablation techniques in China, he also holds great influence and recognition in the global field of minimally invasive cancer diagnosis and treatment.
The academic exchange conducted by Professor Xiao Yueyong carried profound significance. As WATA’s Clinical Model Hospital, Chengdu Uni-Asia Cancer Hospital has always been committed to the application of standardized and continuously innovative minimally invasive tumor ablation technologies. Professor Xiao’s visit was not only an authoritative professional assessment of the hospital’s technical capabilities and specialized development achievements, but also built a direct bridge between the hospital and the most advanced developments in international ablation technology. During the exchange, Professor Xiao and the hospital’s expert team held in-depth discussions on key topics such as the latest advances in cancer interventional therapy, the clinical applications of cryoablation and NanoKnife, strategies for managing complex cases, specialty development, and talent training.
△ Professor Xiao Yueyong (center), Professor Liao Zhengyin (right), and President He Weibing (left) in in-depth discussion
As WATA’s Clinical Model Hospital, Chengdu Uni-Asia Cancer Hospital has always pursued advanced international standards in cancer diagnosis and treatment, focusing on building minimally invasive tumor ablation as a key specialty, while serving as a core medical institution in Southwest China dedicated to standardized and technologically innovative ablation diagnosis and treatment. Leveraging the advantages of the WATA international platform, the hospital continuously connects with advanced global concepts and technological systems in ablation diagnosis and treatment, building a standardized and规范化 platform for minimally invasive cancer treatment. With advantages such as minimal trauma, rapid recovery, high precision, and broad indications, the hospital provides cancer patients with personalized and refined minimally invasive treatment options, significantly improving regional cancer treatment quality and patient outcomes.
Over the years, with the comprehensive support and professional guidance of top experts such as Professor Xiao Yueyong, Professor Liao Zhengyin, and Professor Zhang Jinshan, Chengdu Uni-Asia Cancer Hospital’s ablation specialty has continued to achieve breakthroughs and steady development. The hospital has consistently maintained a leading position in Southwest China in technological innovation, clinical effectiveness, specialty development, and academic research. Not only has it become a model for standardized minimally invasive tumor ablation diagnosis and treatment in the region, but it has also taken on the industry responsibility of technology dissemination, academic exchange promotion, and talent training, continuously driving the standardized and refined development of minimally invasive tumor ablation in Southwest China.
Taking Professor Xiao Yueyong’s visit as an impetus, Chengdu Uni-Asia Cancer Hospital will continue to leverage the advantages of the WATA platform, strengthen academic exchange and technical cooperation with top experts in the field of ablation in China and abroad, and continuously enhance the level of minimally invasive tumor ablation treatment. The hospital is committed to offering more cancer patients precise, safe, and effective treatment options, while contributing “Uni-Asia Strength” to the high-quality development of tumor ablation treatment in China.
